A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion

T. Kuroiwa, Hiroshi Honda, K. Yoshimitsu, H. Irie, H. Aibe, K. Shinozaki, Akihiro Nishie, Tomohiro Nakayama, K. Masuda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this study was to perform a simple percutaneous transfemoral implantation of a portcatheter access system using a new catheter coating for hepatic artery chemotherapy infusion, and to evaluate the complications of transfemoral infusion port implantation. The methods of treatment for complications were also studied. The port-catheter system was percutaneously implanted via femoral artery access in 180 patients with malignant liver tumors. Blood flow redistribution was performed using embolization coils. An unfixed 5 Fr catheter was placed in a hepatic artery, and connected to a port implanted subcutaneously below the level of the inguinal ligament. The success rate of implantation was 99%. Complications after placement were observed as follows: port system obstruction (9.6%); dislocation of the catheter tip (8.4%); drug toxicity (4.5%); and infection (3.4%). Notable is the avoidance of cerebral infarcts. In 3 of 17 patients with port obstruction, recanalization of the port was achieved. In 11 of 15 patients with catheter dislocation, replacement of the catheter-port system was successful. In 5 patients with hepatic artery occlusion, the replacement of a microcatheter-port access system was achieved, and hepatic artery chemotherapy infusion was resumed. This percutaneous transfemoral implantation of a catheter-port access system would seem to be a very simple and useful method for many clinical doctors, and it may improve the quality of life in patients with an unresectable malignant liver tumor.

Original languageEnglish
Pages (from-to)1573-1577
Number of pages5
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume28
Issue number11
Publication statusPublished - Jan 1 2001

Fingerprint

Vascular Access Devices
Hepatic Artery
Drug Therapy
Catheters
Groin
Liver
Femoral Artery
Drug-Related Side Effects and Adverse Reactions
Ligaments
Neoplasms
Quality of Life
Infection

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion. / Kuroiwa, T.; Honda, Hiroshi; Yoshimitsu, K.; Irie, H.; Aibe, H.; Shinozaki, K.; Nishie, Akihiro; Nakayama, Tomohiro; Masuda, K.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 28, No. 11, 01.01.2001, p. 1573-1577.

Research output: Contribution to journalArticle

@article{46299cf3d375450685863edae0616920,
title = "A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion",
abstract = "The purpose of this study was to perform a simple percutaneous transfemoral implantation of a portcatheter access system using a new catheter coating for hepatic artery chemotherapy infusion, and to evaluate the complications of transfemoral infusion port implantation. The methods of treatment for complications were also studied. The port-catheter system was percutaneously implanted via femoral artery access in 180 patients with malignant liver tumors. Blood flow redistribution was performed using embolization coils. An unfixed 5 Fr catheter was placed in a hepatic artery, and connected to a port implanted subcutaneously below the level of the inguinal ligament. The success rate of implantation was 99{\%}. Complications after placement were observed as follows: port system obstruction (9.6{\%}); dislocation of the catheter tip (8.4{\%}); drug toxicity (4.5{\%}); and infection (3.4{\%}). Notable is the avoidance of cerebral infarcts. In 3 of 17 patients with port obstruction, recanalization of the port was achieved. In 11 of 15 patients with catheter dislocation, replacement of the catheter-port system was successful. In 5 patients with hepatic artery occlusion, the replacement of a microcatheter-port access system was achieved, and hepatic artery chemotherapy infusion was resumed. This percutaneous transfemoral implantation of a catheter-port access system would seem to be a very simple and useful method for many clinical doctors, and it may improve the quality of life in patients with an unresectable malignant liver tumor.",
author = "T. Kuroiwa and Hiroshi Honda and K. Yoshimitsu and H. Irie and H. Aibe and K. Shinozaki and Akihiro Nishie and Tomohiro Nakayama and K. Masuda",
year = "2001",
month = "1",
day = "1",
language = "English",
volume = "28",
pages = "1573--1577",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "11",

}

TY - JOUR

T1 - A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion

AU - Kuroiwa, T.

AU - Honda, Hiroshi

AU - Yoshimitsu, K.

AU - Irie, H.

AU - Aibe, H.

AU - Shinozaki, K.

AU - Nishie, Akihiro

AU - Nakayama, Tomohiro

AU - Masuda, K.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The purpose of this study was to perform a simple percutaneous transfemoral implantation of a portcatheter access system using a new catheter coating for hepatic artery chemotherapy infusion, and to evaluate the complications of transfemoral infusion port implantation. The methods of treatment for complications were also studied. The port-catheter system was percutaneously implanted via femoral artery access in 180 patients with malignant liver tumors. Blood flow redistribution was performed using embolization coils. An unfixed 5 Fr catheter was placed in a hepatic artery, and connected to a port implanted subcutaneously below the level of the inguinal ligament. The success rate of implantation was 99%. Complications after placement were observed as follows: port system obstruction (9.6%); dislocation of the catheter tip (8.4%); drug toxicity (4.5%); and infection (3.4%). Notable is the avoidance of cerebral infarcts. In 3 of 17 patients with port obstruction, recanalization of the port was achieved. In 11 of 15 patients with catheter dislocation, replacement of the catheter-port system was successful. In 5 patients with hepatic artery occlusion, the replacement of a microcatheter-port access system was achieved, and hepatic artery chemotherapy infusion was resumed. This percutaneous transfemoral implantation of a catheter-port access system would seem to be a very simple and useful method for many clinical doctors, and it may improve the quality of life in patients with an unresectable malignant liver tumor.

AB - The purpose of this study was to perform a simple percutaneous transfemoral implantation of a portcatheter access system using a new catheter coating for hepatic artery chemotherapy infusion, and to evaluate the complications of transfemoral infusion port implantation. The methods of treatment for complications were also studied. The port-catheter system was percutaneously implanted via femoral artery access in 180 patients with malignant liver tumors. Blood flow redistribution was performed using embolization coils. An unfixed 5 Fr catheter was placed in a hepatic artery, and connected to a port implanted subcutaneously below the level of the inguinal ligament. The success rate of implantation was 99%. Complications after placement were observed as follows: port system obstruction (9.6%); dislocation of the catheter tip (8.4%); drug toxicity (4.5%); and infection (3.4%). Notable is the avoidance of cerebral infarcts. In 3 of 17 patients with port obstruction, recanalization of the port was achieved. In 11 of 15 patients with catheter dislocation, replacement of the catheter-port system was successful. In 5 patients with hepatic artery occlusion, the replacement of a microcatheter-port access system was achieved, and hepatic artery chemotherapy infusion was resumed. This percutaneous transfemoral implantation of a catheter-port access system would seem to be a very simple and useful method for many clinical doctors, and it may improve the quality of life in patients with an unresectable malignant liver tumor.

UR - http://www.scopus.com/inward/record.url?scp=0035487451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035487451&partnerID=8YFLogxK

M3 - Article

C2 - 11707983

AN - SCOPUS:0035487451

VL - 28

SP - 1573

EP - 1577

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 11

ER -